These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 8690899)
1. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses. Palmer LD; Saha B; Hodes RJ; Abe R J Immunol; 1996 Mar; 156(6):2112-8. PubMed ID: 8690899 [TBL] [Abstract][Full Text] [Related]
3. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus. Hodes RJ; Novick MB; Palmer LD; Knepper JE J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408 [TBL] [Abstract][Full Text] [Related]
4. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus. Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306 [TBL] [Abstract][Full Text] [Related]
5. B and T cells are required for mouse mammary tumor virus spread within the mammary gland. Golovkina TV; Dudley JP; Ross SR J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233 [TBL] [Abstract][Full Text] [Related]
6. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination. Champagne E; Scarpellino L; Lane P; Acha-Orbea H Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566 [TBL] [Abstract][Full Text] [Related]
7. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus. Maillard I; Erny K; Acha-Orbea H; Diggelmann H Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159 [TBL] [Abstract][Full Text] [Related]
8. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice. Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259 [TBL] [Abstract][Full Text] [Related]
10. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells. Penninger JM; Wallace VA; Timms E; Mak TW Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521 [TBL] [Abstract][Full Text] [Related]
11. Mouse mammary tumor virus (MMTV), a retrovirus that exploits the immune system. Genetics of susceptibility to MMTV infection. Ross SR; Dzuris JL; Golovkina TV; Clemmons WC; van den Hoogen B Medicina (B Aires); 1997; 57 Suppl 2():34-42. PubMed ID: 9567342 [TBL] [Abstract][Full Text] [Related]
12. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus. Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418 [TBL] [Abstract][Full Text] [Related]
13. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB). Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034 [TBL] [Abstract][Full Text] [Related]
14. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice. Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038 [TBL] [Abstract][Full Text] [Related]
15. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines. Gilfillan MC; Noel PJ; Podack ER; Reiner SL; Thompson CB J Immunol; 1998 Mar; 160(5):2180-7. PubMed ID: 9498756 [TBL] [Abstract][Full Text] [Related]
16. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity. Papiernik M; do Carmo Leite-de-MoraesM ; Pontoux C; Joret AM; Rocha B; Penit C; Dy M J Immunol; 1997 May; 158(10):4642-53. PubMed ID: 9144476 [TBL] [Abstract][Full Text] [Related]
17. Deletion of CD4+ T cells by mouse mammary tumor virus (FM) superantigen with broad specificity of T cell receptor beta-chain variable region. Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H Virology; 1996 Sep; 223(2):387-91. PubMed ID: 8806576 [TBL] [Abstract][Full Text] [Related]
18. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells. Luther SA; Maillard I; Luthi F; Scarpellino L; Diggelmann H; Acha-Orbea H J Immunol; 1997 Sep; 159(6):2807-14. PubMed ID: 9300703 [TBL] [Abstract][Full Text] [Related]